about
Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.Poor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose.Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysis.Citation bias and selective focus on positive findings in the literature on the serotonin transporter gene (5-HTTLPR), life stress and depression.Letter to the Editor: Moving science forward by increasing awareness of reporting and citation biases: a reply to Vrshek-Schallhorn et al. (2016).Retraction of biased journal articles.Evidence-b(i)ased psychiatryHiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trialsThe cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depressionA comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys.Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysisPredicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysisThe antidepressant standoff: why it continues and how to resolve itThe relationship between mental disorders and actual and desired subjective social status
P50
Q34668914-44d4f083-43cf-06d0-3f29-f80c47b0efe6Q37373205-29905E1B-4552-464A-9355-B5BEED2BE3E7Q39360824-7C79F9A7-9E2A-4061-BCC2-DD64B8C2D39EQ39497742-3A9FD7C9-8292-43A6-BF30-DD5435D4E6A6Q40585344-71F4334E-9B1B-45C9-B6A5-2F04847EBE40Q46080679-B6C0B44B-9234-448C-B947-C64E7C977A8BQ55711617-1fb1a395-4b6b-3b33-882c-86e2c8f797f7Q57092529-F367D553-C0F2-4747-9B5E-ADFAE0770202Q58802592-130EE764-A9BD-41FF-B65F-39FBDD36B279Q63684014-F309D562-DCCC-4C8C-8F6E-DCC23C5DE4FAQ88369055-8FBE14F5-B762-4F2B-ABA3-A61EDCD00EE2Q89306549-921E982F-F47B-4B30-B530-301F5E1C25E6Q91518890-C75C91C5-9517-43EA-AFC3-B8102719E8BEQ91988320-7EB551F1-F05E-4670-AEB5-6C15C27B272F
P50
description
Nederlands onderzoekster
@nl
hulumtuese
@sq
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Ymkje Anna de Vries
@ast
Ymkje Anna de Vries
@ca
Ymkje Anna de Vries
@en
Ymkje Anna de Vries
@es
Ymkje Anna de Vries
@fr
Ymkje Anna de Vries
@nl
Ymkje Anna de Vries
@sl
type
label
Ymkje Anna de Vries
@ast
Ymkje Anna de Vries
@ca
Ymkje Anna de Vries
@en
Ymkje Anna de Vries
@es
Ymkje Anna de Vries
@fr
Ymkje Anna de Vries
@nl
Ymkje Anna de Vries
@sl
prefLabel
Ymkje Anna de Vries
@ast
Ymkje Anna de Vries
@ca
Ymkje Anna de Vries
@en
Ymkje Anna de Vries
@es
Ymkje Anna de Vries
@fr
Ymkje Anna de Vries
@nl
Ymkje Anna de Vries
@sl
P106
P21
P214
107152138651010982980
P31
P496
0000-0003-4580-4873
P734
P735
P7859
viaf-107152138651010982980